概括
这项研究纠正了先前发表的DOI文章. 这种纠正确保了科学界的准确引用.
科学领域:
- 这个部分不适用,因为摘要只包含一个纠正通知.
背景情况:
- 这个部分不适用,因为摘要只包含一个纠正通知.
研究的目的:
- 纠正之前发表的文章的数字物体标识符 (DOI).
主要方法:
- 纠正该条款的标识.
主要成果:
- 该物品的数字物体标识符 (DOI) 已更新.
结论:
- 准确的引用对于科学完整性和可重复性至关重要.
相关概念视频
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K